
KMS Medisurgi Ltd Exempted from Corporate Governance Report for Q4 2025
KMS Medisurgi Ltd, a company listed on the BSE SME Platform, has announced that it is exempted from the compliance with the corporate governance provisions as specified in regulations 17, 17A, 18, 19, 20, 21,22, 23, 24, 24A, 25, 26, 27 and clauses (b) to (i) and (t) of sub-regulation (2) of regulation 46 and para C, D and E of Schedule V. This exemption is due to the company's paid up equity share capital not exceeding rupees ten crore and net worth not exceeding rupees twenty five crore, as on the last day of the previous financial year. Consequently, the company is not required to disclose Report on Corporate Governance pursuant to Regulation 27 (2) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 for the Quarter ended 31° December, 2025.
Key Highlights
- KMS Medisurgi Ltd is exempted from corporate governance report for Q4 2025
- The exemption is due to the company's equity share capital and net worth not exceeding the specified limits
- The company is listed on the BSE SME Platform
- The exemption is in accordance with Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- The company is not required to disclose Report on Corporate Governance for Q4 2025
Price Impact
More from KMSMEDI